Home
About
Overview
Sharing Data
ORCID
Help
History (77)
Lymphadenitis
Dermatitis, Occupational
Generalizing findings from a randomized controlled trial to a real-world study of the iLookOut, an online education program to improve early childhood care and education providers' knowledge and attitudes about reporting child maltreatment.
Cannabidiol Knowledge, Perceptions, and Use Among Young Adults in 6 U.S. Metropolitan Areas.
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.
See All 77 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study.
Improved Benefit Risk Profile of Rivaroxaban in a Subpopulation of the MAGELLAN Study. Clin Appl Thromb Hemost. 2019 Jan-Dec; 25:1076029619886022.
View in:
PubMed
subject areas
Administration, Oral
Aged
Anticoagulants
Double-Blind Method
Factor Xa Inhibitors
Female
Humans
Middle Aged
Risk Factors
Rivaroxaban
Venous Thromboembolism
authors with profiles
Gary E Raskob